The molecular genetics of non-ALS motor neuron diseases

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1762, Issue 11-12, 2006, Pages 986-1000

  James, Paul A ^a   Talbot, Kevin ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Axonal transport; Hereditary motor neuropathy; Motor Neuron; Neurodegeneration; Soinal muscular atrophy

Indexed keywords

ALSIN; ATLASTIN 1; DYNACTIN; GENE PRODUCT; GLYCINE TRANSFER RNA LIGASE; HEAT SHOCK PROTEIN; HEAT SHOCK PROTEIN 22; HEAT SHOCK PROTEIN 27; HEAT SHOCK PROTEIN 60; KINESIN; NON IMPRINTED IN PRADDER WILLI ANGELMAN SYNDROME PROTEIN 1; PARAPLEGIN; SEIPIN; SENATAXIN; SPASTIN; UNCLASSIFIED DRUG; VAMP ASSOCIATED PROTEIN B;

CLINICAL FEATURE; GENE MUTATION; HUMAN; MOLECULAR GENETICS; MOTOR NEURON DISEASE; NONHUMAN; PRIORITY JOURNAL; REVIEW;

ADOLESCENT; ADULT; AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; AXONAL TRANSPORT; GTP-BINDING PROTEIN GAMMA SUBUNITS; HEAT-SHOCK PROTEINS; HUMANS; MICE; MICE, TRANSGENIC; MODELS, NEUROLOGICAL; MOTOR NEURON DISEASE; MUSCLES; MUTATION; NEOPLASM PROTEINS; PHENOTYPE; SIGNAL TRANSDUCTION; SYNDROME;

EID: 33750992481     PISSN: 09254439     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbadis.2006.04.003     Document Type: Review

References (174)

1. Shaw P.J., and Eggett C.J. Molecular factors underlying selective vulnerability of motor neurons to neurodegeneration in amyotrophic lateral sclerosis. J. Neurol. 247 Suppl. 1 (2000) I17-I27
2. Franck E., Madsen O., van Rheede T., Ricard G., Huynen M.A., and de Jong W.W. Evolutionary diversity of vertebrate small heat shock proteins. J. Mol. Evol. 59 6 (2004) 792-805
3. Kappe G., Franck E., Verschuure P., Boelens W.C., Leunissen J.A., and de Jong W.W. The human genome encodes 10 alpha-crystallin-related small heat shock proteins: HspB1-10. Cell Stress Chaperones 8 1 (2003) 53-61
4. Evgrafov O.V., Mersiyanova I., Irobi J., Van Den Bosch L., Dierick I., Leung C.L., et al. Mutant small heat-shock protein 27 causes axonal Charcot-Marie-Tooth disease and distal hereditary motor neuropathy. Nat. Genet. 36 6 (2004) 602-606
5. Irobi J., Van Impe K., Seeman P., Jordanova A., Dierick I., Verpoorten N., et al. Hot-spot residue in small heat-shock protein 22 causes distal motor neuropathy. [see comment]. Nat. Genet. 36 6 (2004) 597-601
6. Kijima K., Numakura C., Goto T., Takahashi T., Otagiri T., Umetsu K., et al. Small heat shock protein 27 mutation in a Japanese patient with distal hereditary motor neuropathy. J. Hum. Genet. 50 9 (2005) 473-476
7. Tang B., Liu X., Zhao G., Luo W., Xia K., Pan Q., et al. Mutation analysis of the small heat shock protein 27 gene in Chinese patients with Charcot-Marie-Tooth disease. Arch. Neurol. 62 8 (2005) 1201-1207
8. Ismailov S.M., Fedotov V.P., Dadali E.L., Polyakov A.V., Van Broeckhoven C., Ivanov V.I., et al. A new locus for autosomal dominant Charcot-Marie-Tooth disease type 2 (CMT2F) maps to chromosome 7q11-q21. Eur. J. Hum. Genet. 9 8 (2001) 646-650
9. Benndorf R., Sun X., Gilmont R.R., Biederman K.J., Molloy M.P., Goodmurphy C.W., et al. HSP22, a new member of the small heat shock protein superfamily, interacts with mimic of phosphorylated HSP27 ((3D)HSP27). J. Biol. Chem. 276 29 (2001) 26753-26761
10. Timmerman V., De Jonghe P., Simokovic S., Lofgren A., Beuten J., Nelis E., et al. Distal hereditary motor neuropathy type II (distal HMN II): mapping of a locus to chromosome 12q24. Hum. Mol. Genet. 5 7 (1996) 1065-1069
11. Tang B.S., Luo W., Xia K., Xiao J.F., Jiang H., Shen L., et al. A new locus for autosomal dominant Charcot-Marie-Tooth disease type 2 (CMT2L) maps to chromosome 12q24. Hum. Genet. 114 6 (2004) 527-533
12. Tang B.S., Zhao G.H., Luo W., Xia K., Cai F., Pan Q., et al. Small heat-shock protein 22 mutated in autosomal dominant Charcot-Marie-Tooth disease type 2L. Hum. Genet. 116 3 (2005) 222-224
13. Timmerman V., Raeymaekers P., Nelis E., De Jonghe P., Muylle L., Ceuterick C., et al. Linkage analysis of distal hereditary motor neuropathy type II (distal HMN II) in a single pedigree. J. Neurol. Sci. 109 1 (1992) 41-48
14. Parcellier A., Schmitt E., Brunet M., Hammann A., Solary E., and Garrido C. Small heat shock proteins HSP27 and alphaB-crystallin: cytoprotective and oncogenic functions. Antioxid. Redox Signal. 7 3-4 (2005) 404-413
15. Jakob U., Gaestel M., Engel K., and Buchner J. Small heat shock proteins are molecular chaperones. J. Biol. Chem. 268 3 (1993) 1517-1520
16. Horwitz J. Alpha-crystallin can function as a molecular chaperone. Proc. Natl. Acad. Sci. U. S. A. 89 21 (1992) 10449-10453
17. Carra S., Sivilotti M., Chavez Zobel A.T., Lambert H., and Landry J. HspB8, a small heat shock protein mutated in human neuromuscular disorders, has in vivo chaperone activity in cultured cells. Hum. Mol. Genet. 14 12 (2005) 1659-1669
18. Van Montfort R., Slingsby C., and Vierling E. Structure and function of the small heat shock protein/alpha-crystallin family of molecular chaperones. Adv. Protein Chem. 59 (2001) 105-156
19. Landry J., Lambert H., Zhou M., Lavoie J.N., Hickey E., Weber L.A., et al. Human HSP27 is phosphorylated at serines 78 and 82 by heat shock and mitogen-activated kinases that recognize the same amino acid motif as S6 kinase II. J. Biol. Chem. 267 2 (1992) 794-803
20. Zhou M., Lambert H., and Landry J. Transient activation of a distinct serine protein kinase is responsible for 27-kDa heat shock protein phosphorylation in mitogen-stimulated and heat-shocked cells. J. Biol. Chem. 268 1 (1993) 35-43
21. Kato K., Ito H., Iwamoto I., Lida K., and Inaguma Y. Protein kinase inhibitors can suppress stress-induced dissociation of Hsp27. Cell Stress Chaperones 6 1 (2001) 16-20
22. Friedrich K.L., Giese K.C., Buan N.R., and Vierling E. Interactions between small heat shock protein subunits and substrate in small heat shock protein-substrate complexes. J. Biol. Chem. 279 2 (2004) 1080-1089
23. Arrigo A.P. In search of the molecular mechanism by which small stress proteins counteract apoptosis during cellular differentiation. Journal of Cellular Biochemistry 94 2 (2005) 241-246
24. Bruey J.M., Ducasse C., Bonniaud P., Ravagnan L., Susin S.A., Diaz-Latoud C., et al. Hsp27 negatively regulates cell death by interacting with cytochrome c. Nat. Cell Biol. 2 9 (2000) 645-652
25. Concannon C.G., Gorman A.M., and Samali A. On the role of Hsp27 in regulating apoptosis. Apoptosis 8 1 (2003) 61-70
26. Li Z., Zhao X., and Wei Y. Regulation of apoptotic signal transduction pathways by the heat shock proteins. Sci. China, C Life Sci. 47 2 (2004) 107-114
27. Cooper L.F., Uoshima K., and Guo Z. Transcriptional regulation involving the intronic heat shock element of the rat hsp27 gene. Biochim. Biophys. Acta 1490 3 (2000) 348-354
28. Cuesta R., Laroia G., and Schneider R.J. Chaperone hsp27 inhibits translation during heat shock by binding eIF4G and facilitating dissociation of cap-initiation complexes. Genes Dev. 14 12 (2000) 1460-1470
29. Arrigo A.P. Hsp27: novel regulator of intracellular redox state. IUBMB Life 52 6 (2001) 303-307
30. Arrigo A.P., Firdaus W.J., Mellier G., Moulin M., Paul C., Diaz-latoud C., et al. Cytotoxic effects induced by oxidative stress in cultured mammalian cells and protection provided by Hsp27 expression. Methods (Duluth) 35 2 (2005) 126-138
31. Mehlen P., Preville X., Chareyron P., Briolay J., Klemenz R., and Arrigo A.P. Constitutive expression of human hsp27, Drosophila hsp27, or human alpha B-crystallin confers resistance to TNF- and oxidative stress-induced cytotoxicity in stably transfected murine L929 fibroblasts. J. Immunol. 154 1 (1995) 363-374
32. Loones M.T., Chang Y., and Morange M. The distribution of heat shock proteins in the nervous system of the unstressed mouse embryo suggests a role in neuronal and non-neuronal differentiation. Cell Stress Chaperones 5 4 (2000) 291-305
33. Williams K.L., Rahimtula M., and Mearow K.M. Hsp27 and axonal growth in adult sensory neurons in vitro. BMC Neurosci. 6 1 (2005) 24
34. Soti C., and Csermely P. Chaperones and aging: role in neurodegeneration and in other civilizational diseases. Neurochem. Int. 41 6 (2002) 383-389
35. Clark J.I., and Muchowski P.J. Small heat-shock proteins and their potential role in human disease. Curr. Opin. Struct. Biol. 10 1 (2000) 52-59
36. Muchowski P.J., and Wacker J.L. Modulation of neurodegeneration by molecular chaperones. Nat. Rev., Neurosci. 6 1 (2005) 11-22
37. Vleminckx V., Van Damme P., Goffin K., Delye H., Van Den Bosch L., and Robberecht W. Upregulation of HSP27 in a transgenic model of ALS. J. Neuropathol. Exp. Neurol. 61 11 (2002) 968-974
38. Patel Y.J., Payne Smith M.D., de Belleroche J., and Latchman D.S. Hsp27 and Hsp70 administered in combination have a potent protective effect against FALS-associated SOD1-mutant-induced cell death in mammalian neuronal cells. Brain Res. Mol. Brain Res. 134 2 (2005) 256-274
39. Pasta S.Y., Raman B., Ramakrishna T., and Rao C.M. The IXI/V motif in the C-terminal extension of alpha-crystallins: alternative interactions and oligomeric assemblies. Mol. Vis. 10 (2004) 655-662
40. Ackerley S., James P.A., Kalli A., French S., Davies K.E., and Talbot K. A mutation in the small heat-shock protein HSPB1 leading to distal hereditary motor neuronopathy disrupts neurofilament assembly and the axonal transport of specific cellular cargoes. Hum. Mol. Genet. 15 2 (2006) 347-354
41. Litt M., Kramer P., LaMorticella D.M., Murphey W., Lovrien E.W., and Weleber R.G. Autosomal dominant congenital cataract associated with a missense mutation in the human alpha crystallin gene CRYAA. Hum. Mol. Genet. 7 3 (1998) 471-474
42. Vicart P., Caron A., Guicheney P., Li Z., Prevost M.C., Faure A., et al. A missense mutation in the alphaB-crystallin chaperone gene causes a desmin-related myopathy. Nat. Genet. 20 1 (1998) 92-95
43. Bera S., Thampi P., Cho W.J., and Abraham E.C. A positive charge preservation at position 116 of alpha A-crystallin is critical for its structural and functional integrity. Biochemistry 41 41 (2002) 12421-12426
44. Williams J., Osvath S., Khong T.F., Pearse M., and Power D. Cloning, sequencing and bacterial expression of human glycine tRNA synthetase. Nucleic Acids Res. 23 8 (1995) 1307-1310
45. Christodoulou K., Kyriakides T., Hristova A.H., Georgiou D.M., Kalaydjieva L., Yshpekova B., et al. Mapping of a distal form of spinal muscular atrophy with upper limb predominance to chromosome 7p. Hum. Mol. Genet. 4 9 (1995) 1629-1632
46. Ionasescu V., Searby C., Sheffield V.C., Roklina T., Nishimura D., and Ionasescu R. Autosomal dominant Charcot-Marie-Tooth axonal neuropathy mapped on chromosome 7p (CMT2D). Hum. Mol. Genet. 5 9 (1996) 1373-1375
47. Antonellis A., Ellsworth R.E., Sambuughin N., Puls I., Abel A., Lee-Lin S.Q., et al. Glycyl tRNA synthetase mutations in Charcot-Marie-Tooth disease type 2D and distal spinal muscular atrophy type V. Am. J. Hum. Genet. 72 5 (2003) 1293-1299
48. Sivakumar K., Kyriakides T., Puls I., Nicholson G.A., Funalot B., Antonellis A., et al. Phenotypic spectrum of disorders associated with glycyl-tRNA synthetase mutations. Brain 128 Pt. 10 (2005) 2304-2314
49. Friesen W.J., and Dreyfuss G. Specific sequences of the Sm and Sm-like (Lsm) proteins mediate their interaction with the spinal muscular atrophy disease gene product (SMN). J. Biol. Chem. 275 34 (2000) 26370-26375
50. Jordanova A., Irobi J., Thomas F.P., Van Dijck P., Meerschaert K., Dewil M., et al. Disrupted function and axonal distribution of mutant tyrosyl-tRNA synthetase in dominant intermediate Charcot-Marie-Tooth neuropathy. Nat. Genet. 38 2 (2006) 197-202
51. Schroer T.A. Dynactin. Annu. Rev. Cell Dev. Biol. 20 (2004) 759-779
52. Hafezparast M., Klocke R., Ruhrberg C., Marquardt A., Ahmad-Annuar A., Bowen S., et al. Mutations in dynein link motor neuron degeneration to defects in retrograde transport. Science 300 5620 (2003) 808-812
53. LaMonte B.H., Wallace K.E., Holloway B.A., Shelly S.S., Ascano J., Tokito M., et al. Disruption of dynein/dynactin inhibits axonal transport in motor neurons causing late-onset progressive degeneration. Neuron 34 5 (2002) 715-727
54. Puls I., Jonnakuty C., LaMonte B.H., Holzbaur E.L., Tokito M., Mann E., et al. Mutant dynactin in motor neuron disease. Nat. Genet. 33 4 (2003) 455-456
55. Puls I., Oh S.J., Sumner C.J., Wallace K.E., Floeter M.K., Mann E.A., et al. Distal spinal and bulbar muscular atrophy caused by dynactin mutation. Ann. Neurol. 57 5 (2005) 687-694
56. Munch C., Rosenbohm A., Sperfeld A.D., Uttner I., Reske S., Krause B.J., et al. Heterozygous R1101K mutation of the DCTN1 gene in a family with ALS and FTD. Ann. Neurol. 58 5 (2005) 777-780
57. Munch C., Sedlmeier R., Meyer T., Homberg V., Sperfeld A.D., Kurt A., et al. Point mutations of the p150 subunit of dynactin (DCTN1) gene in ALS. Neurology 63 4 (2004) 724-726
58. Ahmad-Annuar A., Shah P., Hafezparast M., Hummerich H., Witherden A.S., Morrison K.E., et al. No association with common Caucasian genotypes in exons 8, 13 and 14 of the human cytoplasmic dynein heavy chain gene (DNCHC1) and familial motor neuron disorders. Amyotroph. Lateral. Scler. Other Motor. Neuron Disord. 4 3 (2003) 150-157
59. Hentati A., Bejaoui K., Pericak-Vance M.A., Hentati F., Speer M.C., Hung W.Y., et al. Linkage of recessive familial amyotrophic lateral sclerosis to chromosome 2q33-q35. Nat. Genet. 7 3 (1994) 425-428
60. Hadano S., Hand C.K., Osuga H., Yanagisawa Y., Otomo A., Devon R.S., et al. A gene encoding a putative GTPase regulator is mutated in familial amyotrophic lateral sclerosis 2. Nat. Genet. 29 2 (2001) 166-173
61. Yang Y., Hentati A., Deng H.X., Dabbagh O., Sasaki T., Hirano M., et al. The gene encoding alsin, a protein with three guanine-nucleotide exchange factor domains, is mutated in a form of recessive amyotrophic lateral sclerosis. Nat. Genet. 29 2 (2001) 160-165
62. Devon R.S., Helm J.R., Rouleau G.A., Leitner Y., Lerman-Sagie T., Lev D., et al. The first nonsense mutation in alsin results in a homogeneous phenotype of infantile-onset ascending spastic paralysis with bulbar involvement in two siblings. Clin. Genet. 64 3 (2003) 210-215
63. Eymard-Pierre E., Lesca G., Dollet S., Santorelli F.M., di Capua M., Bertini E., et al. Infantile-onset ascending hereditary spastic paralysis is associated with mutations in the alsin gene. Am. J. Hum. Genet. 71 3 (2002) 518-527
64. Gros-Louis F., Meijer I.A., Hand C.K., Dube M.P., MacGregor D.L., Seni M.H., et al. An ALS2 gene mutation causes hereditary spastic paraplegia in a Pakistani kindred. Ann. Neurol. 53 1 (2003) 144-145
65. Lesca G., Eymard-Pierre E., Santorelli F.M., Cusmai R., Di Capua M., Valente E.M., et al. Infantile ascending hereditary spastic paralysis (IAHSP): clinical features in 11 families. Neurology 60 4 (2003) 674-682
66. Gascon G.G., Chavis P., Yaghmour A., Stigsby B., Shums A., Ozand P., et al. Familial childhood primary lateral sclerosis with associated gaze paresis. Neuropediatrics 26 6 (1995) 313-319
67. Ben Hamida M., Hentati F., and Ben Hamida C. Hereditary motor system diseases (chronic juvenile amyotrophic lateral sclerosis). Conditions combining a bilateral pyramidal syndrome with limb and bulbar amyotrophy. Brain 113 Pt 2 (1990) 347-363
68. Otomo A., Hadano S., Okada T., Mizumura H., Kunita R., Nishijima H., et al. ALS2, a novel guanine nucleotide exchange factor for the small GTPase Rab5, is implicated in endosomal dynamics. Hum. Mol. Genet. 12 14 (2003) 1671-1687
69. Tudor E.L., Perkinton M.S., Schmidt A., Ackerley S., Brownlees J., Jacobsen N.J., et al. ALS2/Alsin regulates Rac-PAK signaling and neurite outgrowth. J. Biol. Chem. 280 41 (2005) 34735-34740
70. Topp J.D., Gray N.W., Gerard R.D., and Horazdovsky B.F. Alsin is a Rab5 and Rac1 guanine nucleotide exchange factor. J. Biol. Chem. 279 23 (2004) 24612-24623
71. Zerial M. Regulation of endocytosis by the small GTP-ase rab5. Cytotechnology 11 Suppl. 1 (1993) S47-S49
72. Yamanaka K., Vande Velde C., Eymard-Pierre E., Bertini E., Boespflug-Tanguy O., and Cleveland D.W. Unstable mutants in the peripheral endosomal membrane component ALS2 cause early-onset motor neuron disease. Proc. Natl. Acad. Sci. U. S. A. 100 26 (2003) 16041-16046
73. Kunita R., Otomo A., Mizumura H., Suzuki K., Showguchi-Miyata J., Yanagisawa Y., et al. Homo-oligomerization of ALS2 through its unique carboxyl-terminal regions is essential for the ALS2-associated Rab5 guanine nucleotide exchange activity and its regulatory function on endosome trafficking. J. Biol. Chem. 279 37 (2004) 38626-38635
74. Grabham P.W., Reznik B., and Goldberg D.J. Microtubule and Rac 1-dependent F-actin in growth cones. J. Cell Sci. 116 Pt 18 (2003) 3739-3748
75. Kuhn T.B., Brown M.D., and Bamburg J.R. Rac1-dependent actin filament organization in growth cones is necessary for beta1-integrin-mediated advance but not for growth on poly-d-lysine. J. Neurobiol. 37 4 (1998) 524-540
76. Kanekura K., Hashimoto Y., Niikura T., Aiso S., Matsuoka M., and Nishimoto I. Alsin, the product of ALS2 gene, suppresses SOD1 mutant neurotoxicity through RhoGEF domain by interacting with SOD1 mutants. J. Biol. Chem. 279 18 (2004) 19247-19256
77. Hadano S., Benn S.C., Kakuta S., Otomo A., Sudo K., Kunita R., et al. Mice deficient in the Rab5 guanine nucleotide exchange factor ALS2/alsin exhibit age-dependent neurological deficits and altered endosome trafficking. Hum. Mol. Genet. 15 2 (2006) 233-250
78. Rabin B.A., Griffin J.W., Crain B.J., Scavina M., Chance P.F., and Cornblath D.R. Autosomal dominant juvenile amyotrophic lateral sclerosis. Brain 122 Pt. 8 (1999) 1539-1550
79. Chen Y.Z., Bennett C.L., Huynh H.M., Blair I.P., Puls I., Irobi J., et al. DNA/RNA helicase gene mutations in a form of juvenile amyotrophic lateral sclerosis (ALS4). Am. J. Hum. Genet. 74 6 (2004) 1128-1135
80. Chance P.F., Rabin B.A., Ryan S.G., Ding Y., Scavina M., Crain B., et al. Linkage of the gene for an autosomal dominant form of juvenile amyotrophic lateral sclerosis to chromosome 9q34. Am. J. Hum. Genet. 62 3 (1998) 633-640
81. De Jonghe P., Auer-Grumbach M., Irobi J., Wagner K., Plecko B., Kennerson M., et al. Autosomal dominant juvenile amyotrophic lateral sclerosis and distal hereditary motor neuronopathy with pyramidal tract signs: synonyms for the same disorder?. Brain 125 Pt 6 (2002) 1320-1325
82. Moreira M.C., Klur S., Watanabe M., Nemeth A.H., Le Ber I., Moniz J.C., et al. Senataxin, the ortholog of a yeast RNA helicase, is mutant in ataxia-ocular apraxia 2. Nat. Genet. 36 3 (2004) 225-227
83. Duquette A., Roddier K., McNabb-Baltar J., Gosselin I., St-Denis A., Dicaire M.J., et al. Mutations in senataxin responsible for Quebec cluster of ataxia with neuropathy. Ann. Neurol. 57 3 (2005) 408-414
84. Le Ber I., Brice A., and Durr A. New autosomal recessive cerebellar ataxias with oculomotor apraxia. Curr. Neurol. Neurosci. Rep. 5 5 (2005) 411-417
85. Grohmann K., Schuelke M., Diers A., Hoffmann K., Lucke B., Adams C., et al. Mutations in the gene encoding immunoglobulin mu-binding protein 2 cause spinal muscular atrophy with respiratory distress type 1. Nat. Genet. 29 1 (2001) 75-77
86. Nishimura A.L., Mitne-Neto M., Silva H.C., Oliveira J.R., Vainzof M., and Zatz M. A novel locus for late onset amyotrophic lateral sclerosis/motor neurone disease variant at 20q13. J. Med. Genet. 41 4 (2004) 315-320
87. Nishimura A.L., Mitne-Neto M., Silva H.C., Richieri-Costa A., Middleton S., Cascio D., et al. A mutation in the vesicle-trafficking protein VAPB causes late-onset spinal muscular atrophy and amyotrophic lateral sclerosis. Am. J. Hum. Genet. 75 5 (2004) 822-831
88. Nishimura A.L., Al-Chalabi A., and Zatz M. A common founder for amyotrophic lateral sclerosis type 8 (ALS8) in the Brazilian population. Hum. Genet. (2005) 1-2
89. Nishimura Y., Hayashi M., Inada H., and Tanaka T. Molecular cloning and characterization of mammalian homologues of vesicle-associated membrane protein-associated (VAMP-associated) proteins. Biochem. Biophys. Res. Commun. 254 1 (1999) 21-26
90. Pennetta G., Hiesinger P., Fabian-Fine R., Meinertzhagen I., and Bellen H. Drosophila VAP-33A directs bouton formation at neuromuscular junctions in a dosage-dependent manner. Neuron 35 2 (2002) 291-306
91. Skehel P.A., Martin K.C., Kandel E.R., and Bartsch D. A VAMP-binding protein from Aplysia required for neurotransmitter release. Science 269 5230 (1995) 1580-1583
92. Skehel P.A., Fabian-Fine R., and Kandel E.R. Mouse VAP33 is associated with the endoplasmic reticulum and microtubules. Proc. Natl. Acad. Sci. U. S. A. 97 3 (2000) 1101-1106
93. Silver J.R. Familial spastic paraplegia with amyotrophy of the hands. Ann. Hum. Genet. 30 1 (1966) 69-75
94. Patel H., Hart P.E., Warner T.T., Houlston R.S., Patton M.A., Jeffery S., et al. The Silver syndrome variant of hereditary spastic paraplegia maps to chromosome 11q12-q14, with evidence for genetic heterogeneity within this subtype. Am. J. Hum. Genet. 69 1 (2001) 209-215
95. Auer-Grumbach M., Loscher W.N., Wagner K., Petek E., Korner E., Offenbacher H., et al. Phenotypic and genotypic heterogeneity in hereditary motor neuronopathy type V: a clinical, electrophysiological and genetic study. Brain 123 Pt 8 (2000) 1612-1623
96. Windpassinger C., Auer-Grumbach M., Irobi J., Patel H., Petek E., Horl G., et al. Heterozygous missense mutations in BSCL2 are associated with distal hereditary motor neuropathy and Silver syndrome. Nat. Genet. 36 3 (2004) 271-276
97. Auer-Grumbach M., Schlotter-Weigel B., Lochmuller H., Strobl-Wildemann G., Auer-Grumbach P., Fischer R., et al. Phenotypes of the N88S Berardinelli-Seip congenital lipodystrophy 2 mutation. Ann. Neurol. 57 3 (2005) 415-424
98. Irobi J., Van den Bergh P., Merlini L., Verellen C., Van Maldergem L., Dierick I., et al. The phenotype of motor neuropathies associated with BSCL2 mutations is broader than Silver syndrome and distal HMN type V. Brain 127 Pt 9 (2004) 2124-2130
99. Magre J., Delepine M., Khallouf E., Gedde-Dahl Jr. T., Van Maldergem L., Sobel E., et al. Identification of the gene altered in Berardinelli-Seip congenital lipodystrophy on chromosome 11q13. Nat. Genet. 28 4 (2001) 365-370
100. Agarwal A.K., and Garg A. Seipin: a mysterious protein. Trends Mol. Med. 10 9 (2004) 440-444
101. Mendonca D.M., Chimelli L., and Martinez A.M. Quantitative evidence for neurofilament heavy subunit aggregation in motor neurons of spinal cords of patients with amyotrophic lateral sclerosis. Braz. J. Med. Biol. Res. 38 6 (2005) 925-933
102. Cote F., Collard J.F., and Julien J.P. Progressive neuronopathy in transgenic mice expressing the human neurofilament heavy gene: a mouse model of amyotrophic lateral sclerosis. Cell 73 1 (1993) 35-46
103. Xu Z., Cork L.C., Griffin J.W., and Cleveland D.W. Increased expression of neurofilament subunit NF-L produces morphological alterations that resemble the pathology of human motor neuron disease. Cell 73 1 (1993) 23-33
104. Al-Chalabi A., Andersen P.M., Nilsson P., Chioza B., Andersson J.L., Russ C., et al. Deletions of the heavy neurofilament subunit tail in amyotrophic lateral sclerosis. Hum. Mol. Genet. 8 2 (1999) 157-164
105. Figlewicz D.A., Krizus A., Martinoli M.G., Meininger V., Dib M., Rouleau G.A., et al. Variants of the heavy neurofilament subunit are associated with the development of amyotrophic lateral sclerosis. Hum. Mol. Genet. 3 10 (1994) 1757-1761
106. Rooke K., Figlewicz D.A., Han F.Y., and Rouleau G.A. Analysis of the KSP repeat of the neurofilament heavy subunit in familiar amyotrophic lateral sclerosis. Neurology 46 3 (1996) 789-790
107. Vechio J.D., Bruijn L.I., Xu Z., Brown Jr. R.H., and Cleveland D.W. Sequence variants in human neurofilament proteins: absence of linkage to familial amyotrophic lateral sclerosis. Ann. Neurol. 40 4 (1996) 603-610
108. Skvortsova V., Shadrina M., Slominsky P., Levitsky G., Kondratieva E., Zherebtsova A., et al. Analysis of heavy neurofilament subunit gene polymorphism in Russian patients with sporadic motor neuron disease (MND). Eur. J. Hum. Genet. 12 3 (2004) 241-244
109. Fabrizi G.M., Cavallaro T., Angiari C., Bertolasi L., Cabrini I., Ferrarini M., et al. Giant axon and neurofilament accumulation in Charcot-Marie-Tooth disease type 2E. Neurology 62 8 (2004) 1429-1431
110. Georgiou D.M., Zidar J., Korosec M., Middleton L.T., Kyriakides T., and Christodoulou K. A novel NF-L mutation Pro22Ser is associated with CMT2 in a large Slovenian family. Neurogenetics 4 2 (2002) 93-96
111. Jordanova A., De Jonghe P., Boerkoel C.F., Takashima H., De Vriendt E., Ceuterick C., et al. Mutations in the neurofilament light chain gene (NEFL) cause early onset severe Charcot-Marie-Tooth disease. Brain 126 Pt 3 (2003) 590-597
112. Mersiyanova I.V., Perepelov A.V., Polyakov A.V., Sitnikov V.F., Dadali E.L., Oparin R.B., et al. A new variant of Charcot-Marie-Tooth disease type 2 is probably the result of a mutation in the neurofilament-light gene. Am. J. Hum. Genet. 67 1 (2000) 37-46
113. Fink J.K., and Rainier S. Hereditary spastic paraplegia: spastin phenotype and function. Arch. Neurol. 61 6 (2004) 830-833
114. Hazan J., Fonknechten N., Mavel D., Paternotte C., Samson D., Artiguenave F., et al. Spastin, a new AAA protein, is altered in the most frequent form of autosomal dominant spastic paraplegia. Nat. Genet. 23 3 (1999) 296-303
115. Sauter S., Miterski B., Klimpe S., Bonsch D., Schols L., Visbeck A., et al. Mutation analysis of the spastin gene (SPG4) in patients in Germany with autosomal dominant hereditary spastic paraplegia. Hum. Mutat. 20 2 (2002) 127-132
116. Meijer I.A., Hand C.K., Cossette P., Figlewicz D.A., Rouleau G.A., et al. Spectrum of SPG4 mutations in a large collection of North American families with hereditary spastic paraplegia. Arch. Neurol. 59 2 (2002) 281-286
117. Brugman F., Wokke J.H., Scheffer H., Versteeg M.H., Sistermans E.A., and van den Berg L.H. Spastin mutations in sporadic adult-onset upper motor neuron syndromes. Ann. Neurol. 58 6 (2005) 865-869
118. Depienne C., Tallaksen C., Lephay J.Y., Bricka B., Poea-Guyon S., Fontaine B., et al. Spastin mutations are frequent in sporadic spastic paraparesis and their spectrum is different from the one observed in familial cases. J. Med. Genet. 43 3 (2005) 259-265
119. Fonknechten N., Mavel D., Byrne P., Davoine C.S., Cruaud C., Bonsch D., et al. Spectrum of SPG4 mutations in autosomal dominant spastic paraplegia. Hum. Mol. Genet. 9 4 (2000) 637-644
120. Yip A.G., Durr A., Marchuk D.A., Ashley-Koch A., Hentati A., Rubinsztein D.C., et al. Meta-analysis of age at onset in spastin-associated hereditary spastic paraplegia provides no evidence for a correlation with mutational class. J. Med. Genet. 40 9 (2003) e106
121. Nielsen J.E., Johnsen B., Koefoed P., Scheuer K.H., Gronbech-Jensen M., Law I., et al. Hereditary spastic paraplegia with cerebellar ataxia: a complex phenotype associated with a new SPG4 gene mutation. Eur. J. Neurol. 11 12 (2004) 817-824
122. Alber B., Pernauer M., Schwan A., Rothmund G., Hoffmann K.T., Brummer D., et al. Spastin related hereditary spastic paraplegia with dysplastic corpus callosum. J. Neurol. Sci. 236 1-2 (2005) 9-12
123. Orlacchio A., Kawarai T., Totaro A., Errico A., St George-Hyslop P.H., Rugarli E.I., et al. Hereditary spastic paraplegia: clinical genetic study of 15 families. Arch. Neurol. 61 6 (2004) 849-855
124. Byrne P.C., Mc Monagle P., Webb S., Fitzgerald B., Parfrey N.A., and Hutchinson M. Age-related cognitive decline in hereditary spastic paraparesis linked to chromosome 2p. Neurology 54 7 (2000) 1510-1517
125. Byrne P.C., Webb S., McSweeney F., Burke T., Hutchinson M., and Parfrey N.A. Linkage of AD HSP and cognitive impairment to chromosome 2p: haplotype and phenotype analysis indicates variable expression and low or delayed penetrance. Eur. J. Hum. Genet. 6 3 (1998) 275-282
126. McMonagle P., Byrne P., and Hutchinson M. Further evidence of dementia in SPG4-linked autosomal dominant hereditary spastic paraplegia. Neurology 62 3 (2004) 407-410
127. Reid E., Grayson C., Rubinsztein D.C., Rogers M.T., and Rubinsztein J.S. Subclinical cognitive impairment in autosomal dominant "pure" hereditary spastic paraplegia. J. Med. Genet. 36 10 (1999) 797-798
128. Wharton S.B., McDermott C.J., Grierson A.J., Wood J.D., Gelsthorpe C., Ince P.G., et al. The cellular and molecular pathology of the motor system in hereditary spastic paraparesis due to mutation of the spastin gene. J. Neuropathol. Exp. Neurol. 62 11 (2003) 1166-1177
129. White K.D., Ince P.G., Lusher M., Lindsey J., Cookson M., Bashir R., et al. Clinical and pathologic findings in hereditary spastic paraparesis with spastin mutation. Neurology 55 1 (2000) 89-94
130. Svenson I.K., Ashley-Koch A.E., Gaskell P.C., Riney T.J., Cumming W.J., Kingston H.M., et al. Identification and expression analysis of spastin gene mutations in hereditary spastic paraplegia. Am J. Hum. Genet. 68 5 (2001) 1077-1085
131. Svenson I.K., Ashley-Koch A.E., Pericak-Vance M.A., and Marchuk D.A. A second leaky splice-site mutation in the spastin gene. Am J. Hum. Genet. 69 6 (2001) 1407-1409
132. Reid E., Connell J., Edwards T.L., Duley S., Brown S.E., and Sanderson C.M. The hereditary spastic paraplegia protein spastin interacts with the ESCRT-III complex-associated endosomal protein CHMP1B. Hum. Mol. Genet. 14 1 (2005) 19-38
133. Charvin D., Cifuentes-Diaz C., Fonknechten N., Joshi V., Hazan J., Melki J., et al. Mutations of SPG4 are responsible for a loss of function of spastin, an abundant neuronal protein localized in the nucleus. Hum. Mol. Genet. 12 1 (2003) 71-78
134. Beetz C., Brodhun M., Moutzouris K., Kiehntopf M., Berndt A., Lehnert D., et al. Identification of nuclear localisation sequences in spastin (SPG4) using a novel Tetra-GFP reporter system. Biochem. Biophys. Res. Commun. 318 4 (2004) 1079-1084
135. Errico A., Claudiani P., D'Addio M., and Rugarli E.I. Spastin interacts with the centrosomal protein NA14, and is enriched in the spindle pole, the midbody and the distal axon. Hum. Mol. Genet. 13 18 (2004) 2121-2132
136. McNally F.J., and Vale R.D. Identification of katanin, an ATPase that severs and disassembles stable microtubules. Cell 75 3 (1993) 419-429
137. McDermott C.J., Grierson A.J., Wood J.D., Bingley M., Wharton S.B., Bushby K.M., et al. Hereditary spastic paraparesis: disrupted intracellular transport associated with spastin mutation. Ann. Neurol. 54 6 (2003) 748-759
138. Errico A., Ballabio A., and Rugarli E.I. Spastin, the protein mutated in autosomal dominant hereditary spastic paraplegia, is involved in microtubule dynamics. Hum. Mol. Genet. 11 2 (2002) 153-163
139. Evans K.J., Gomes E.R., Reisenweber S.M., Gundersen G.G., and Lauring B.P. Linking axonal degeneration to microtubule remodeling by Spastin-mediated microtubule severing. J. Cell Biol. 168 4 (2005) 599-606
140. Trotta N., Orso G., Rossetto M.G., Daga A., and Broadie K. The hereditary spastic paraplegia gene, spastin, regulates microtubule stability to modulate synaptic structure and function. Curr. Biol. 14 13 (2004) 1135-1147
141. Zhao X., Alvarado D., Rainier S., Lemons R., Hedera P., Weber C.H., et al. Mutations in a newly identified GTPase gene cause autosomal dominant hereditary spastic paraplegia. Nat. Genet. 29 3 (2001) 326-331
142. Durr A., Camuzat A., Colin E., Tallaksen C., Hannequin D., Coutinho P., et al. Atlastin1 mutations are frequent in young-onset autosomal dominant spastic paraplegia. Arch. Neurol. 61 12 (2004) 1867-1872
143. Abel A., Fonknechten N., Hofer A., Durr A., Cruaud C., Voit T., et al. Early onset autosomal dominant spastic paraplegia caused by novel mutations in SPG3A. Neurogenetics 5 4 (2004) 239-243
144. Wilkinson P.A., Hart P.E., Patel H., Warner T.T., and Crosby A.H. SPG3A mutation screening in English families with early onset autosomal dominant hereditary spastic paraplegia. J. Neurol. Sci. 216 1 (2003) 43-45
145. D'Amico A., Tessa A., Sabino A., Bertini E., Santorelli F.M., and Servidei S. Incomplete penetrance in an SPG3A-linked family with a new mutation in the atlastin gene. Neurology 62 11 (2004) 2138-2139
146. Sauter S.M., Engel W., Neumann L.M., Kunze J., and Neesen J. Novel mutations in the Atlastin gene (SPG3A) in families with autosomal dominant hereditary spastic paraplegia and evidence for late onset forms of HSP linked to the SPG3A locus. Hum. Mutat. 23 1 (2004) 98
147. Scarano V., Mancini P., Criscuolo C., De Michele G., Rinaldi C., Tucci T., et al. The R495W mutation in SPG3A causes spastic paraplegia associated with axonal neuropathy. J. Neurol. 252 8 (2005) 901-903
148. Tessa A., Casali C., Damiano M., Bruno C., Fortini D., Patrono C., et al. SPG3A: an additional family carrying a new atlastin mutation. Neurology 59 12 (2002) 2002-2005
149. Dalpozzo F., Rossetto M.G., Boaretto F., Sartori E., Mostacciuolo M.L., Daga A., et al. Infancy onset hereditary spastic paraplegia associated with a novel atlastin mutation. Neurology 61 4 (2003) 580-581
150. Hedera P., Fenichel G.M., Blair M., and Haines J.L. Novel mutation in the SPG3A gene in an African American family with an early onset of hereditary spastic paraplegia. Arch. Neurol. 61 10 (2004) 1600-1603
151. Muglia M., Magariello A., Nicoletti G., Patitucci A., Gabriele A.L., Conforti F.L., et al. Further evidence that SPG3A gene mutations cause autosomal dominant hereditary spastic paraplegia. Ann. Neurol. 51 6 (2002) 794-795
152. Zhu P.P., Patterson A., Lavoie B., Stadler J., Shoeb M., Patel R., et al. Cellular localization, oligomerization, and membrane association of the hereditary spastic paraplegia 3A (SPG3A) protein atlastin. J. Biol. Chem. 278 49 (2003) 49063-49071
153. Zuchner S., Noureddine M., Kennerson M., Verhoeven K., Claeys K., De Jonghe P., et al. Mutations in the pleckstrin homology domain of dynamin 2 cause dominant intermediate Charcot-Marie-Tooth disease. Nat. Genet. 37 3 (2005) 289-294
154. De Michele G., De Fusco M., Cavalcanti F., Filla A., Marconi R., Volpe G., et al. A new locus for autosomal recessive hereditary spastic paraplegia maps to chromosome 16q24.3. Am. J. Hum. Genet. 63 1 (1998) 135-139
155. Casari G., De Fusco M., Ciarmatori S., Zeviani M., Mora M., Fernandez P., et al. Spastic paraplegia and OXPHOS impairment caused by mutations in paraplegin, a nuclear-encoded mitochondrial metalloprotease. Cell 93 6 (1998) 973-983
156. McDermott C.J., Dayaratne R.K., Tomkins J., Lusher M.E., Lindsey J.C., Johnson M.A., et al. Paraplegin gene analysis in hereditary spastic paraparesis (HSP) pedigrees in northeast England. Neurology 56 4 (2001) 467-471
157. Wilkinson P.A., Crosby A.H., Turner C., Bradley L.J., Ginsberg L., Wood N.W., et al. A clinical, genetic and biochemical study of SPG7 mutations in hereditary spastic paraplegia. Brain 127 Pt 5 (2004) 973-980
158. Langer T., Kaser M., Klanner C., and Leonhard K. AAA proteases of mitochondria: quality control of membrane proteins and regulatory functions during mitochondrial biogenesis. Biochem. Soc. Trans. 29 Pt 4 (2001) 431-436
159. Ferreirinha F., Quattrini A., Pirozzi M., Valsecchi V., Dina G., Broccoli V., et al. Axonal degeneration in paraplegin-deficient mice is associated with abnormal mitochondria and impairment of axonal transport. J. Clin. Invest. 113 2 (2004) 231-242
160. Fontaine B., Davoine C.S., Durr A., Paternotte C., Feki I., Weissenbach J., et al. A new locus for autosomal dominant pure spastic paraplegia, on chromosome 2q24-q34. Am. J. Hum. Genet. 66 2 (2000) 702-707
161. Hansen J.J., Durr A., Cournu-Rebeix I., Georgopoulos C., Ang D., Nielsen M.N., et al. Hereditary spastic paraplegia SPG13 is associated with a mutation in the gene encoding the mitochondrial chaperonin Hsp60. Am. J. Hum. Genet. 70 5 (2002) 1328-1332
162. Kanai Y., Okada Y., Tanaka Y., Harada A., Terada S., and Hirokawa N. KIF5C, a novel neuronal kinesin enriched in motor neurons. J. Neurosci. 20 17 (2000) 6374-6384
163. Blair M.A., Ma S., and Hedera P. Mutation in KIF5A can also cause adult-onset hereditary spastic paraplegia. Neurogenetics 7 1 (2006) 47-50
164. Fichera M., Lo Giudice M., Falco M., Sturnio M., Amata S., Calabrese O., et al. Evidence of kinesin heavy chain (KIF5A) involvement in pure hereditary spastic paraplegia. Neurology 63 6 (2004) 1108-1110
165. Lo Giudice M., Neri M., Falco M., Sturnio M., Calzolari E., Di Benedetto D., et al. A missense mutation in the coiled-coil domain of the KIF5A gene and late-onset hereditary spastic paraplegia. Arch. Neurol. 63 2 (2006) 284-287
166. Reid E., Kloos M., Ashley-Koch A., Hughes L., Bevan S., Svenson I.K., et al. A kinesin heavy chain (KIF5A) mutation in hereditary spastic paraplegia (SPG10). Am. J. Hum. Genet. 71 5 (2002) 1189-1194
167. Zhao C., Takita J., Tanaka Y., Setou M., Nakagawa T., Takeda S., et al. Charcot-Marie-Tooth disease type 2A caused by mutation in a microtubule motor KIF1Bbeta. Cell 105 5 (2001) 587-597
168. Zuchner S., Mersiyanova I.V., Muglia M., Bissar-Tadmouri N., Rochelle J., Dadali E.L., et al. Mutations in the mitochondrial GTPase mitofusin 2 cause Charcot-Marie-Tooth neuropathy type 2A. Nat. Genet. 36 5 (2004) 449-451
169. Chen S., Song C., Guo H., Xu P., Huang W., Zhou Y., et al. Distinct novel mutations affecting the same base in the NIPA1 gene cause autosomal dominant hereditary spastic paraplegia in two Chinese families. Hum. Mutat. 25 2 (2005) 135-141
170. Munhoz R.P., Kawarai T., Teive H.A., Raskin S., Sato C., Liang Y., et al. Clinical and genetic study of a Brazilian family with spastic paraplegia (SPG6 locus). Mov. Disord. 21 2 (2005) 279-281
171. Rainier S., Chai J.H., Tokarz D., Nicholls R.D., and Fink J.K. NIPA1 gene mutations cause autosomal dominant hereditary spastic paraplegia (SPG6). Am. J. Hum. Genet. 73 4 (2003) 967-971
172. Reed J.A., Wilkinson P.A., Patel H., Simpson M.A., Chatonnet A., Robay D., et al. A novel NIPA1 mutation associated with a pure form of autosomal dominant hereditary spastic paraplegia. Neurogenetics 6 2 (2005) 79-84
173. Skibinski G., Parkinson N.J., Brown J.M., Chakrabarti L., Lloyd S.L., Hummerich H., et al. Mutations in the endosomal ESCRTIII-complex subunit CHMP2B in frontotemporal dementia. Nat. Genet. 37 8 (2005) 806-808
174. Schmitt-John T., Drepper C., Mussmann A., Hahn P., Kuhlmann M., Thiel C., et al. Mutation of Vps54 causes motor neuron disease and defective spermiogenesis in the wobbler mouse. Nat. Genet. 37 11 (2005) 1213-1215